NO994364L - Dolastatin 15 derivater med karbonyl og heterocykliske funksjonaliteter ved C-terminal ende - Google Patents

Dolastatin 15 derivater med karbonyl og heterocykliske funksjonaliteter ved C-terminal ende

Info

Publication number
NO994364L
NO994364L NO994364A NO994364A NO994364L NO 994364 L NO994364 L NO 994364L NO 994364 A NO994364 A NO 994364A NO 994364 A NO994364 A NO 994364A NO 994364 L NO994364 L NO 994364L
Authority
NO
Norway
Prior art keywords
group
dolastatin
carbonyl
derivatives
terminal end
Prior art date
Application number
NO994364A
Other languages
English (en)
Norwegian (no)
Other versions
NO994364D0 (no
Inventor
Kurt Ritter
Wilhelm Amberg
Teresa Barlozzari
Andreas Haupt
Bernd Janssen
Andreas Kling
Original Assignee
Basf Ag
Basf Bioresearch Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Basf Bioresearch Corp filed Critical Basf Ag
Publication of NO994364D0 publication Critical patent/NO994364D0/no
Publication of NO994364L publication Critical patent/NO994364L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO994364A 1997-03-10 1999-09-09 Dolastatin 15 derivater med karbonyl og heterocykliske funksjonaliteter ved C-terminal ende NO994364L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/814,577 US5965537A (en) 1997-03-10 1997-03-10 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
PCT/US1998/004317 WO1998040400A1 (en) 1997-03-10 1998-03-05 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus

Publications (2)

Publication Number Publication Date
NO994364D0 NO994364D0 (no) 1999-09-09
NO994364L true NO994364L (no) 1999-11-09

Family

ID=25215470

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994364A NO994364L (no) 1997-03-10 1999-09-09 Dolastatin 15 derivater med karbonyl og heterocykliske funksjonaliteter ved C-terminal ende

Country Status (17)

Country Link
US (1) US5965537A (es)
EP (1) EP0981539A1 (es)
JP (1) JP2001518084A (es)
KR (1) KR20000076099A (es)
CN (1) CN1252806A (es)
AR (1) AR011957A1 (es)
AU (1) AU744511B2 (es)
BR (1) BR9808017A (es)
CA (1) CA2297164A1 (es)
CO (1) CO4950525A1 (es)
HR (1) HRP980124A2 (es)
HU (1) HUP0001758A3 (es)
IL (1) IL131596A0 (es)
NO (1) NO994364L (es)
TW (1) TW505657B (es)
WO (1) WO1998040400A1 (es)
ZA (1) ZA981957B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
SK6282003A3 (en) 2000-10-30 2004-02-03 Janssen Pharmaceutica Nv Tripeptidyl peptidase inhibitors
US7256257B2 (en) * 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US6884869B2 (en) * 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
DK1545613T3 (da) * 2002-07-31 2011-11-14 Seattle Genetics Inc Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
DE10240818A1 (de) * 2002-08-30 2004-05-13 Grünenthal GmbH Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DK1725249T3 (en) 2003-11-06 2014-03-17 Seattle Genetics Inc Monomethylvaline compounds capable of conjugating to ligands.
EP1883627B1 (en) 2005-05-18 2018-04-18 Pharmascience Inc. Bir domain binding compounds
CN101535300B (zh) 2006-05-16 2014-05-28 埃格拉医疗公司 Iap bir域结合化合物
CL2008002085A1 (es) 2007-07-16 2008-11-21 Genentech Inc Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
MX341687B (es) 2010-02-10 2016-08-30 Immunogen Inc "anticuerpos cd20 y su utilización".
NZ602368A (en) 2010-02-12 2014-10-31 Pharmascience Inc Iap bir domain binding compounds
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
WO2016086357A1 (en) * 2014-12-02 2016-06-09 Merck Sharp & Dohme Corp. Methyl oxazole orexin receptor antagonists
WO2016100162A2 (en) * 2014-12-19 2016-06-23 Merck Sharp & Dohme Corp. 5,5-bicyclic oxazole orexin receptor antagonists
CN104952808A (zh) * 2015-06-12 2015-09-30 广州先艺电子科技有限公司 一种预置金锡盖板及其制造方法
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220150408A (ko) 2016-11-14 2022-11-10 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN109776342A (zh) * 2019-02-26 2019-05-21 北京大学深圳研究生院 顺式β-氨基酸及其衍生物的合成方法
US20240132487A1 (en) * 2019-10-17 2024-04-25 Givaudan Sa Substituted azacyles as trmp8 modulators
CA3230737A1 (en) 2021-09-03 2023-03-09 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
US5091368A (en) * 1990-08-08 1992-02-25 Harbor Branch Oceanographic Institution, Inc. Biologically active compounds from blue-green algae
CA2115355C (en) * 1991-08-09 2007-09-11 Kyoichi Sakakibara Novel tetrapeptide derivative
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
CA2136339C (en) * 1992-05-20 2008-02-05 Andreas Haupt Derivatives of dolastatin
CA2151953A1 (en) * 1992-12-16 1994-06-23 Andreas Haupt "dolostatin analog" (novel peptides, the preparation and use thereof)
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5554725A (en) * 1994-09-14 1996-09-10 Arizona Board Of Regents Acting On Behalf Of Arizona State University Synthesis of dolastatin 15
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof

Also Published As

Publication number Publication date
KR20000076099A (ko) 2000-12-26
NO994364D0 (no) 1999-09-09
CA2297164A1 (en) 1998-09-17
BR9808017A (pt) 2000-03-08
AR011957A1 (es) 2000-09-13
TW505657B (en) 2002-10-11
AU6448298A (en) 1998-09-29
WO1998040400A1 (en) 1998-09-17
CO4950525A1 (es) 2000-09-01
ZA981957B (en) 1999-09-09
AU744511B2 (en) 2002-02-28
HUP0001758A3 (en) 2001-12-28
IL131596A0 (en) 2001-01-28
EP0981539A1 (en) 2000-03-01
CN1252806A (zh) 2000-05-10
HRP980124A2 (en) 1998-12-31
HUP0001758A2 (hu) 2001-05-28
JP2001518084A (ja) 2001-10-09
US5965537A (en) 1999-10-12

Similar Documents

Publication Publication Date Title
NO994364L (no) Dolastatin 15 derivater med karbonyl og heterocykliske funksjonaliteter ved C-terminal ende
DE69530936T2 (de) Boronsäure-und-esterverbindungen, deren systhese und verwendungen
US4692458A (en) Anti-hypertensive agents
NO20000231L (no) Dolastatin-15-derivater
DE19914474A1 (de) Aminosäurederivate
EP0315574A2 (de) Renin-Inhibitoren
EP0035383B1 (en) Angiotensin converting enzyme inhibitors
PL342608A1 (en) Novel heterocyclic compounds, method of obtaining them, pharmacological compositions containing such compounds and their application in treating diabetes and its associated diseases
US4745124A (en) Orally effective anti-hypertensive agents
NO943852L (no) Fremgangsmåte for å hemme bentap
EA010852B1 (ru) Пиперидиновые соединения и фармацевтические композиции, их содержащие
DE3840452A1 (de) (beta)-amino-boronsaeure-derivate
KR100593601B1 (ko) 성장호르몬 방출성을 가진 화합물
DE19632773A1 (de) Neue Thrombininhibitoren
EP0508220B1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel
KR930007969A (ko) 17β- 치환된 아자 - 안드로스탄 유도체
CA2315679A1 (en) Vitamin e derivatives
DE3913272A1 (de) Dipeptid-derivate mit enzym-inhibitorischer wirkung
NO20044964L (no) Flytende preparat som omfatter camptothecinderivat og farmasoytisk preparat som kan fremstilles ved a lyofilisere preparatet
DE3842067A1 (de) Enzym-hemmende aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
WO1998004278A3 (en) Tetrapeptide derivatives of dolastatin as antitumor agents
EP0230242A2 (de) Substituierte 4-Amino-3-hydroxy-buttersäure-Derivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
DE3839126A1 (de) Renin-hemmende harnstoffderivate von dipeptiden, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
US7375085B1 (en) Melanocyte-stimulating hormone inhibitors
US4734420A (en) Anti-hypertensive agents